Ignite Creation Date:
2025-12-18 @ 6:56 AM
Ignite Modification Date:
2025-12-23 @ 6:58 PM
Study NCT ID:
NCT00745264
Status:
None
Last Update Posted:
2009-03-20 00:00:00
First Post:
2008-09-02 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise
Sponsor:
None
Organization:
Study Overview
Official Title:
Multi-Centre, Open-Label, Two Segment, Parallel Group Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise
Status:
None
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
* Comparison of the plasma PK after single use of 100 mg ketoprofen from Diractin®. 50 mg applied on 2 major joints to
* 400 mg ketoprofen from Diractin® (100 mg applied to 4 joints - overexposure)
* 100 mg and 400 mg ketoprofen from Diractin® used concomitant with heat application
* 100 mg and 400 mg ketoprofen from Diractin® used concomitant with moderate exercise
* 400 mg ketoprofen from Diractin® (100 mg applied to 4 joints - overexposure)
* 100 mg and 400 mg ketoprofen from Diractin® used concomitant with heat application
* 100 mg and 400 mg ketoprofen from Diractin® used concomitant with moderate exercise
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: